Dialysable leukocyte extracts modify the course of experimental paracoccidioidomycosis in the Syrian hamster

Mycopathologia. 1993 Mar;121(3):149-56. doi: 10.1007/BF01104070.

Abstract

The effect of dialysable leukocyte extracts (DLE) obtained from hamsters immunized with Paracoccidioides brasiliensis (immune DLE) and from non-immunized hamsters (non-immune DLE) was studied in hamsters inoculated with P. brasiliensis by the intratesticular route. Treatment with immune or non-immune DLE was started during the third week of infection and was repeated at 7, 11, 15 and 19 weeks. A group of untreated infected animals was used as control. Animals were submitted to the delayed hypersensitivity skin test to P. brasiliensis antigen (PbAg) in vivo and assayed in vitro by the macrophage migration inhibition test in the presence of Phytohemagglutinin (PHA) and PbAg and by immunodiffusion for specific antibody. The animals were sacrificed at 4, 8, 12, 16 and 20 weeks. The morphology and extension of the lesions were studied at the inoculation site, and in lymph nodes, lungs, liver, spleen and kidneys. In contrast to the controls, animals treated with both DLEs maintained a positive cell-mediated immune response throughout the experiment and developed less extensive infection with a significantly lower number of fungi in the lesions. The results suggest that immune and non-immune DLE preparations modified the evolution of experimental paracoccidioidomycosis with equal efficiency. This similarity may be explained by the immunoregulatory activities of both extracts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Fungal / immunology
  • Cell Extracts / therapeutic use*
  • Cricetinae
  • Immunization, Passive
  • Immunotherapy
  • Leukocytes / immunology*
  • Male
  • Mesocricetus
  • Paracoccidioides / immunology*
  • Paracoccidioides / isolation & purification
  • Paracoccidioidomycosis / immunology
  • Paracoccidioidomycosis / microbiology
  • Paracoccidioidomycosis / pathology
  • Paracoccidioidomycosis / therapy*

Substances

  • Antibodies, Fungal
  • Cell Extracts